The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults
University of New Hampshire
45 participants
Feb 8, 2023
INTERVENTIONAL
Conditions
Summary
This clinical trial aims to learn about the alterations in insulin resistance and metabolic flexibility following a transition to an obesogenic lifestyle in fit young men and women. The main questions it aims to answer are: 1. Does adding excess carbohydrates when transitioning to a sedentary lifestyle promote insulin resistance and impaired 24hr glucose regulation in healthy men and women? 2. Does adding excess carbohydrates when transitioning to a sedentary lifestyle lower the body's ability to break down fats and carbohydrates in healthy men and women? 3. Does the added physical activity blunt shifts in carbohydrate and fat oxidation in healthy men and women?
Eligibility
Inclusion Criteria3
- years of age
- Recreationally active completing 75-150 minutes of moderate-to-vigorous intensity exercise (\>2 days/week).
- Fair cardiorespiratory fitness levels (Men: VO2\>38.4 ml/kg/min; Women: VO2\>32.6 ml/kg/min).
Exclusion Criteria7
- Hypertension (resting or diagnosed)
- Impaired fasting blood glucose (\>100mg/dL)
- Diagnosed cardiovascular disease
- Diagnosed diabetes
- Diagnosed cancer
- Diagnosed chronic kidney disease
- Diagnosed musculoskeletal disorders that prevents the individual from exercising on a bike.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Young men and women will transition into a low physically active lifestyle for 10 days and consume added sugar-sweetened beverages. The intervention group will be compared to two control groups and one experimental group. One of the control groups will undergo a low physical activity intervention.
Young men and women will transition into a low physically active lifestyle for 10 days.
Young men and women will transition into a high physically active lifestyle for 10 days and consume added sugar-sweetened beverages. The intervention group will be compared to two control groups and one experimental group.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05912348